Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 87227002 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Gregory B. Phillips |
Attorney Docket Number | REOXC.034T |
Law Office Assigned | L90 |
Employee Name | BIBB, SCOTT |
2016-11-04 | Application Filed |
2017-10-24 | Published for Opposition |
2017-12-19 | Location: INTENT TO USE SECTION |
2019-12-09 | Status: Live/Pending |
2019-12-11 | Transaction Date |
Owner: | ![]() |
Address | 1488 W. PLEASANT VIEW DRIVE, SUITE 150 PLEASANT GROVE WY 84602 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | WY |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0051 | personal lubricants, medicated moisturizers, pharmaceutical products, pharmaceutical preparations, microbicides and drugs for medical purposes for treatment and prevention of sexually transmitted infections, viral, fungal and bacterial disease, namely, bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), human immunodeficiency virus (HIV), gonorrhea and syphilis; chemical and biological preparations, substances for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); reagents for medical purposes; pharmaceutical preparations containing polyvalent compounds, synthetic molecules and dendrimers for medical purposes for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), Acquired Immune Deficiency Syndrome (AIDS); antimicrobial preparations, namely, microbicidial preparations in the nature of gels, foams, creams, films, solutions, suppositories, suspensions and lotions for vaginal, rectal and transdermal use for treatment and prevention of bacterial vaginosis, Chlamydia, herpes simplex virus, human papilloma virus, hepatitis, human immunodeficiency virus (HIV), herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS) |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-11-08 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-11-08 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-02-11 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-02-11 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-02-11 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-02-11 | 6 GNRN O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-06-23 | 7 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-06-23 | 8 ARAA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-08-09 | 9 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-08-09 | 10 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-08-10 | 11 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-09-14 | 12 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-10-04 | 13 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-10-24 | 14 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-24 | 15 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-12-19 | 16 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-06-18 | 17 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-06-18 | 18 EXT1 S: |
EXTENSION 1 GRANTED | 2018-06-18 | 19 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-06-20 | 20 EXRA E:E-Mail |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2018-07-25 | 21 ASGN I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2018-12-13 | 22 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-12-13 | 23 EXT2 S: |
EXTENSION 2 GRANTED | 2018-12-13 | 24 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-12-15 | 25 EXRA E:E-Mail |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-03-06 | 26 ASGN I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2019-06-14 | 27 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2019-06-14 | 28 EXT3 S: |
EXTENSION 3 GRANTED | 2019-06-14 | 29 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-18 | 30 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-12-09 | 31 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2019-12-09 | 32 EXT4 S: |
EXTENSION 4 GRANTED | 2019-12-09 | 33 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-11 | 34 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-06-09 | 35 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-06-25 | 36 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2020-06-09 | 37 EXT5 S: |
EXTENSION 5 GRANTED | 2020-06-27 | 38 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-06-30 | 39 EXRA E:E-Mail |
ABANDONMENT - NO USE STATEMENT FILED | 2021-01-25 | 40 ABN6 S: |
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-01-25 | 41 MAB6 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.